Status:
COMPLETED
Comparison of Immunogenicity of Inactivated Poliovirus Vaccine (IPV) Administered Intramuscularly or Intradermally
Lead Sponsor:
Instituto Nacional de Saúde, Mozambique
Collaborating Sponsors:
World Health Organization
Conditions:
Polio
Eligibility:
All Genders
2-2 years
Phase:
PHASE2
Brief Summary
Polio is an acute transmissible disease caused by any of the three polio virus serotypes (types 1, 2 or 3). In Mozambique, polio vaccination is part of the immunization schedule of the expanded vaccin...
Eligibility Criteria
Inclusion
- Children whose parents/guardians consent to their participation;
- Children whose parents/guardians live in the study area and do not intend to depart during the study period.
Exclusion
- Children whose parents are under the legal age with exception of 16-years-old parents who are already living in marital status;
- Children whose parents have mental illness;
- Children with immunosuppression.
Key Trial Info
Start Date :
August 6 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2022
Estimated Enrollment :
382 Patients enrolled
Trial Details
Trial ID
NCT04027036
Start Date
August 6 2020
End Date
May 31 2022
Last Update
January 31 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Instituto Nacional de Saúde-Mozambique CISPOC
Maputo, Mozambique, 21-462867
2
INSMozambique
Maputo, Mozambique